203 related articles for article (PubMed ID: 21488187)
21. Cyclin B1 expression and p53 status in squamous cell carcinomas of the head and neck.
Hoffmann TK; Trellakis S; Okulicz K; Schuler P; Greve J; Arnolds J; Bergmann C; Bas M; Lang S; Lehnerdt G; Brandau S; Mattheis S; Scheckenbach K; Finn OJ; Whiteside TL; Sonkoly E
Anticancer Res; 2011 Oct; 31(10):3151-7. PubMed ID: 21965721
[TBL] [Abstract][Full Text] [Related]
22. Constitutive activation of cyclin B1-associated cdc2 kinase overrides p53-mediated G2-M arrest.
Park M; Chae HD; Yun J; Jung M; Kim YS; Kim SH; Han MH; Shin DY
Cancer Res; 2000 Feb; 60(3):542-5. PubMed ID: 10676633
[TBL] [Abstract][Full Text] [Related]
23. USP39 mediates p21-dependent proliferation and neoplasia of colon cancer cells by regulating the p53/p21/CDC2/cyclin B1 axis.
Yuan J; Li X; Zhang G; Cheng W; Wang W; Lei Y; Ma Q; Song G
Mol Carcinog; 2021 Apr; 60(4):265-278. PubMed ID: 33634905
[TBL] [Abstract][Full Text] [Related]
24. Expression of the G2-M checkpoint regulators cyclin B1 and cdc2 in nonmalignant and malignant human breast lesions: immunocytochemical and quantitative image analyses.
Kawamoto H; Koizumi H; Uchikoshi T
Am J Pathol; 1997 Jan; 150(1):15-23. PubMed ID: 9006317
[TBL] [Abstract][Full Text] [Related]
25. Low expression of p27 protein combined with altered p53 and Rb/p16 expression status is associated with increased expression of cyclin A and cyclin B1 in diffuse large B-cell lymphomas.
Bai M; Vlachonikolis J; Agnantis NJ; Tsanou E; Dimou S; Nicolaides C; Stefanaki S; Pavlidis N; Kanavaros P
Mod Pathol; 2001 Nov; 14(11):1105-13. PubMed ID: 11706071
[TBL] [Abstract][Full Text] [Related]
26. YAP enhances the pro-proliferative transcriptional activity of mutant p53 proteins.
Di Agostino S; Sorrentino G; Ingallina E; Valenti F; Ferraiuolo M; Bicciato S; Piazza S; Strano S; Del Sal G; Blandino G
EMBO Rep; 2016 Feb; 17(2):188-201. PubMed ID: 26691213
[TBL] [Abstract][Full Text] [Related]
27. Most basal-like breast carcinomas demonstrate the same Rb-/p16+ immunophenotype as the HPV-related poorly differentiated squamous cell carcinomas which they resemble morphologically.
Subhawong AP; Subhawong T; Nassar H; Kouprina N; Begum S; Vang R; Westra WH; Argani P
Am J Surg Pathol; 2009 Feb; 33(2):163-75. PubMed ID: 18936692
[TBL] [Abstract][Full Text] [Related]
28. Possible associations among expression of p14(ARF), p16(INK4a), p21(WAF1/CIP1), p27(KIP1), and p53 accumulation and the balance of apoptosis and cell proliferation in ovarian carcinomas.
Saegusa M; Machida B D; Okayasu I
Cancer; 2001 Sep; 92(5):1177-89. PubMed ID: 11571731
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of cyclin B1 in patients with esophageal squamous cell carcinoma.
Takeno S; Noguchi T; Kikuchi R; Uchida Y; Yokoyama S; Müller W
Cancer; 2002 Jun; 94(11):2874-81. PubMed ID: 12115375
[TBL] [Abstract][Full Text] [Related]
30. Primate-specific RFPL1 gene controls cell-cycle progression through cyclin B1/Cdc2 degradation.
Bonnefont J; Laforge T; Plastre O; Beck B; Sorce S; Dehay C; Krause KH
Cell Death Differ; 2011 Feb; 18(2):293-303. PubMed ID: 20725088
[TBL] [Abstract][Full Text] [Related]
31. Nuclear cyclin B1 in human breast carcinoma as a potent prognostic factor.
Suzuki T; Urano T; Miki Y; Moriya T; Akahira J; Ishida T; Horie K; Inoue S; Sasano H
Cancer Sci; 2007 May; 98(5):644-51. PubMed ID: 17359284
[TBL] [Abstract][Full Text] [Related]
32. Changes in cyclins and cyclin-dependent kinases induced by DNA damaging agents in a human ovarian cancer cell line expressing mutated or wild-type P53.
Vikhanskaya F; Erba E; D'Incalci M; Broggini M
Exp Cell Res; 1996 Sep; 227(2):380-5. PubMed ID: 8831577
[TBL] [Abstract][Full Text] [Related]
33. Elevation of cyclin B1, active cdc2, and HuR in cervical neoplasia with human papillomavirus type 18 infection.
Cho NH; Kang S; Hong S; An HJ; Choi YH; Jeong GB; Choi HK
Cancer Lett; 2006 Feb; 232(2):170-8. PubMed ID: 16458113
[TBL] [Abstract][Full Text] [Related]
34. TIS21/BTG2/PC3 is expressed through PKC-delta pathway and inhibits binding of cyclin B1-Cdc2 and its activity, independent of p53 expression.
Ryu MS; Lee MS; Hong JW; Hahn TR; Moon E; Lim IK
Exp Cell Res; 2004 Sep; 299(1):159-70. PubMed ID: 15302583
[TBL] [Abstract][Full Text] [Related]
35. Role of cyclin B1/Cdc2 in mediating Bcl-XL phosphorylation and apoptotic cell death following nocodazole-induced mitotic arrest.
Choi HJ; Zhu BT
Mol Carcinog; 2014 Feb; 53(2):125-37. PubMed ID: 22949227
[TBL] [Abstract][Full Text] [Related]
36. Alterations of p16-pRb pathway and chromosome locus 9p21-22 in sporadic invasive breast carcinomas.
Gorgoulis VG; Koutroumbi EN; Kotsinas A; Zacharatos P; Markopoulos C; Giannikos L; Kyriakou V; Voulgaris Z; Gogas I; Kittas C
Mol Med; 1998 Dec; 4(12):807-22. PubMed ID: 9990866
[TBL] [Abstract][Full Text] [Related]
37. Analysis of p53, p16(INK4a), pRb and Cyclin D1 expression and human papillomavirus in primary ovarian serous carcinomas.
Bilyk OO; Pande NT; Buchynska LG
Exp Oncol; 2011 Sep; 33(3):150-6. PubMed ID: 21956468
[TBL] [Abstract][Full Text] [Related]
38. Different p53 genotypes regulating different phosphorylation sites and subcellular location of CDC25C associated with the formation of polyploid giant cancer cells.
Liu K; Zheng M; Zhao Q; Zhang K; Li Z; Fu F; Zhang H; Du J; Li Y; Zhang S
J Exp Clin Cancer Res; 2020 May; 39(1):83. PubMed ID: 32393310
[TBL] [Abstract][Full Text] [Related]
39. Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancer.
Agarwal R; Gonzalez-Angulo AM; Myhre S; Carey M; Lee JS; Overgaard J; Alsner J; Stemke-Hale K; Lluch A; Neve RM; Kuo WL; Sorlie T; Sahin A; Valero V; Keyomarsi K; Gray JW; Borresen-Dale AL; Mills GB; Hennessy BT
Clin Cancer Res; 2009 Jun; 15(11):3654-62. PubMed ID: 19470724
[TBL] [Abstract][Full Text] [Related]
40. Autoantibody detection to tumor-associated antigens of P53, IMP1, P16, cyclin B1, P62, C-myc, Survivn, and Koc for the screening of high-risk subjects and early detection of esophageal squamous cell carcinoma.
Zhou SL; Yue WB; Fan ZM; Du F; Liu BC; Li B; Han XN; Ku JW; Zhao XK; Zhang P; Cui J; Zhou FY; Zhang LQ; Fan XP; Zhou YF; Zhu LL; Liu HY; Wang LD
Dis Esophagus; 2014; 27(8):790-7. PubMed ID: 24147952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
